These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24885714)

  • 1. Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy.
    Maganda BA; Minzi OM; Kamuhabwa AA; Ngasala B; Sasi PG
    Malar J; 2014 May; 13():205. PubMed ID: 24885714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment.
    Maganda BA; Ngaimisi E; Kamuhabwa AA; Aklillu E; Minzi OM
    Malar J; 2015 Apr; 14():179. PubMed ID: 25906774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.
    Kredo T; Mauff K; Van der Walt JS; Wiesner L; Maartens G; Cohen K; Smith P; Barnes KI
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5616-23. PubMed ID: 21947399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of artemether-lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial.
    Banda CG; Chaponda M; Mukaka M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J; Sikalima J; Kalilani-Phiri L; Terlouw DJ; Khoo SH; Lalloo DG; Mwapasa V
    Malar J; 2019 May; 18(1):180. PubMed ID: 31126288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.
    Maganda BA; Minzi OM; Ngaimisi E; Kamuhabwa AA; Aklillu E
    Pharmacogenomics J; 2016 Feb; 16(1):88-95. PubMed ID: 25963334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.
    Byakika-Kibwika P; Lamorde M; Mayito J; Nabukeera L; Namakula R; Mayanja-Kizza H; Katabira E; Ntale M; Pakker N; Ryan M; Hanpithakpong W; Tarning J; Lindegardh N; de Vries PJ; Khoo S; Back D; Merry C
    J Antimicrob Chemother; 2012 Sep; 67(9):2213-21. PubMed ID: 22687893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial.
    Sevene E; Banda CG; Mukaka M; Maculuve S; Macuacua S; Vala A; Piqueras M; Kalilani-Phiri L; Mallewa J; Terlouw DJ; Khoo SH; Lalloo DG; Mwapasa V
    Malar J; 2019 Aug; 18(1):277. PubMed ID: 31429785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nevirapine, efavirenz and lopinavir/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria.
    Usman SO; Oreagba IA; Akinyede AA; Agbaje EO; Akinleye MO; Onwujuobi AG; Ken-Owotor C; Adeuja O; Ogunfowokan T; Kogbe S; Owolabi ET; Adeniji H; Busari AW; Hassan OO; Abideen G; Akanmu AS
    J Pharmacol Sci; 2020 Nov; 144(3):95-101. PubMed ID: 32921396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers.
    Huang L; Parikh S; Rosenthal PJ; Lizak P; Marzan F; Dorsey G; Havlir D; Aweeka FT
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):310-6. PubMed ID: 22918158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India.
    Bharti PK; Shukla MM; Ringwald P; Krishna S; Singh PP; Yadav A; Mishra S; Gahlot U; Malaiya JP; Kumar A; Prasad S; Baghel P; Singh M; Vadadi J; Singh MP; Bustos MD; Ortega LI; Christophel EM; Kashyotia SS; Sonal GS; Singh N
    Malar J; 2016 Oct; 15(1):498. PubMed ID: 27737665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study.
    Chandra R; Ansah P; Sagara I; Sie A; Tiono AB; Djimde AA; Zhao Q; Robbins J; Penali LK; Ogutu B
    Malar J; 2015 Mar; 14():108. PubMed ID: 25881046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.
    Parikh S; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Gao Q; Li F; Were M; Kakuru A; Achan J; Mwebaza N; Aweeka FT
    Clin Infect Dis; 2016 Aug; 63(3):414-22. PubMed ID: 27143666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.
    Achan J; Kakuru A; Ikilezi G; Ruel T; Clark TD; Nsanzabana C; Charlebois E; Aweeka F; Dorsey G; Rosenthal PJ; Havlir D; Kamya MR
    N Engl J Med; 2012 Nov; 367(22):2110-8. PubMed ID: 23190222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi.
    Nyangulu W; Mungwira RG; Divala TH; Nampota-Nkomba N; Nyirenda OM; Buchwald AG; Miller J; Earland DE; Adams M; Plowe CV; Taylor TE; Mallewa JE; van Oosterhout JJ; Parikh S; Laurens MB; Laufer MK;
    Malar J; 2023 Jan; 22(1):32. PubMed ID: 36707795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
    Hughes E; Mwebaza N; Huang L; Kajubi R; Nguyen V; Nyunt MM; Orukan F; Mwima MW; Parikh S; Aweeka F
    J Acquir Immune Defic Syndr; 2020 Feb; 83(2):140-147. PubMed ID: 31929402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of generic artemether-lumefantrine in the treatment of uncomplicated malaria in Ghana: assessing anti-malarial efficacy amidst pharmacogenetic variations.
    Thomford NE; Kellermann T; Biney RP; Dixon C; Nyarko SB; Ateko RO; Ekor M; Kyei GB
    Malar J; 2024 Apr; 23(1):125. PubMed ID: 38685044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, Randomized, Multicenter Trial in India and Africa.
    Toure OA; Mwapasa V; Sagara I; Gaye O; Thompson R; Maheshwar AV; Mishra P; Behra N; Tshefu AK; Das RR; Anvikar AR; Sharma P; Roy A; Sharma SK; Nasa A; Jalali RK; Valecha N;
    Clin Infect Dis; 2017 Oct; 65(10):1711-1720. PubMed ID: 29020247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
    Juma EA; Obonyo CO; Akhwale WS; Ogutu BR
    Malar J; 2008 Dec; 7():262. PubMed ID: 19102746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan.
    Elamin SB; Awad AI; Eltayeb IB; Elmardi KA; Hassan AH; Mohamed AO; Malik EM; Mohamad TA
    Eur J Clin Pharmacol; 2010 Mar; 66(3):231-7. PubMed ID: 20187287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia.
    Hamainza B; Masaninga F; Moonga H; Mwenda M; Chanda-kapata P; Chalwe V; Chanda E; Kamuliwo M; Babaniyi OA
    Malar J; 2014 Nov; 13():430. PubMed ID: 25403945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.